BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23610422)

  • 1. Nontoxic radioactive Listeria(at) is a highly effective therapy against metastatic pancreatic cancer.
    Quispe-Tintaya W; Chandra D; Jahangir A; Harris M; Casadevall A; Dadachova E; Gravekamp C
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8668-73. PubMed ID: 23610422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic cancer: Radioactive Listeria delivers killer hit to metastatic pancreatic cancer.
    Ray K
    Nat Rev Gastroenterol Hepatol; 2013 Jun; 10(6):322. PubMed ID: 23648934
    [No Abstract]   [Full Text] [Related]  

  • 3. 32-Phosphorus selectively delivered by listeria to pancreatic cancer demonstrates a strong therapeutic effect.
    Chandra D; Selvanesan BC; Yuan Z; Libutti SK; Koba W; Beck A; Zhu K; Casadevall A; Dadachova E; Gravekamp C
    Oncotarget; 2017 Mar; 8(13):20729-20740. PubMed ID: 28186976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-agent combinatorial cancer therapy.
    Stritzker J; Szalay AA
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8325-6. PubMed ID: 23667150
    [No Abstract]   [Full Text] [Related]  

  • 5.
    Selvanesan BC; Chandra D; Quispe-Tintaya W; Jahangir A; Patel A; Meena K; Alves Da Silva RA; Friedman M; Gabor L; Khouri O; Libutti SK; Yuan Z; Li J; Siddiqui S; Beck A; Tesfa L; Koba W; Chuy J; McAuliffe JC; Jafari R; Entenberg D; Wang Y; Condeelis J; DesMarais V; Balachandran V; Zhang X; Lin K; Gravekamp C
    Sci Transl Med; 2022 Mar; 14(637):eabc1600. PubMed ID: 35320003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted radionuclide therapies for pancreatic cancer.
    Shah M; Da Silva R; Gravekamp C; Libutti SK; Abraham T; Dadachova E
    Cancer Gene Ther; 2015 Aug; 22(8):375-9. PubMed ID: 26227823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High efficacy of a Listeria-based vaccine against metastatic breast cancer reveals a dual mode of action.
    Kim SH; Castro F; Paterson Y; Gravekamp C
    Cancer Res; 2009 Jul; 69(14):5860-6. PubMed ID: 19584282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodies.
    Kim VM; Blair AB; Lauer P; Foley K; Che X; Soares K; Xia T; Muth ST; Kleponis J; Armstrong TD; Wolfgang CL; Jaffee EM; Brockstedt D; Zheng L
    J Immunother Cancer; 2019 May; 7(1):132. PubMed ID: 31113479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ARF tumor suppressor inhibits tumor cell colonization independent of p53 in a novel mouse model of pancreatic ductal adenocarcinoma metastasis.
    Muniz VP; Barnes JM; Paliwal S; Zhang X; Tang X; Chen S; Zamba KD; Cullen JJ; Meyerholz DK; Meyers S; Davis JN; Grossman SR; Henry MD; Quelle DE
    Mol Cancer Res; 2011 Jul; 9(7):867-77. PubMed ID: 21636682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid-derived suppressor cells have a central role in attenuated Listeria monocytogenes-based immunotherapy against metastatic breast cancer in young and old mice.
    Chandra D; Jahangir A; Quispe-Tintaya W; Einstein MH; Gravekamp C
    Br J Cancer; 2013 Jun; 108(11):2281-90. PubMed ID: 23640395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal Bioluminescence Imaging of Primary Versus Abdominal Metastatic Tumor Growth in Orthotopic Pancreatic Tumor Models in NSG Mice.
    Shannon HE; Fishel ML; Xie J; Gu D; McCarthy BP; Riley AA; Sinn AL; Silver JM; Peterman K; Kelley MR; Hanenberg H; Korc M; Pollok KE; Territo PR
    Pancreas; 2015 Jan; 44(1):64-75. PubMed ID: 25406955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic and therapeutic efficacy of an attenuated Listeria monocytogenes-based vaccine delivering HPV16 E7 in a mouse model.
    Jia Y; Yin Y; Duan F; Fu H; Hu M; Gao Y; Pan Z; Jiao X
    Int J Mol Med; 2012 Dec; 30(6):1335-42. PubMed ID: 23027427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid-derived suppressor cells: Cellular missiles to target tumors.
    Chandra D; Gravekamp C
    Oncoimmunology; 2013 Nov; 2(11):e26967. PubMed ID: 24427545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological effects of low-dose-rate irradiation of pancreatic carcinoma cells in vitro using 125I seeds.
    Wang ZM; Lu J; Zhang LY; Lin XZ; Chen KM; Chen ZJ; Liu FJ; Yan FH; Teng GJ; Mao AW
    World J Gastroenterol; 2015 Feb; 21(8):2336-42. PubMed ID: 25741139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Organ-targeting and Cellular Characteristics of Metastatic Human Pancreatic Cancer Cell Lines in Mouse Models.
    Satake T; Suetsugu A; Nakamura M; Hasegawa K; Kunisada T; Shimizu M; Saji S; Moriwaki H; Hoffman RM
    Anticancer Res; 2018 Apr; 38(4):1927-1935. PubMed ID: 29599308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-targeting amino acid auxotrophic Salmonella typhimurium.
    Hoffman RM
    Amino Acids; 2009 Sep; 37(3):509-21. PubMed ID: 19291366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel "patient-like" treatment model of human pancreatic cancer constructed using orthotopic transplantation of histologically intact human tumor tissue in nude mice.
    Furukawa T; Kubota T; Watanabe M; Kitajima M; Hoffman RM
    Cancer Res; 1993 Jul; 53(13):3070-2. PubMed ID: 8319214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhenium-188 Labeled Tungsten Disulfide Nanoflakes for Self-Sensitized, Near-Infrared Enhanced Radioisotope Therapy.
    Chao Y; Wang G; Liang C; Yi X; Zhong X; Liu J; Gao M; Yang K; Cheng L; Liu Z
    Small; 2016 Aug; 12(29):3967-75. PubMed ID: 27345460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-clinical study of 213Bi labeled PAI2 for the control of micrometastatic pancreatic cancer.
    Qu CF; Song EY; Li Y; Rizvi SM; Raja C; Smith R; Morgenstern A; Apostolidis C; Allen BJ
    Clin Exp Metastasis; 2005; 22(7):575-86. PubMed ID: 16475028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-associated antigen expressing Listeria monocytogenes induces effective primary and memory T-cell responses against hepatic colorectal cancer metastases.
    Olino K; Wada S; Edil BH; Pan X; Meckel K; Weber W; Slansky J; Tamada K; Lauer P; Brockstedt D; Pardoll D; Schulick R; Yoshimura K
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3(Suppl 3):S597-607. PubMed ID: 21979110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.